Do we understand the personalized medicine paradigm?: Personalized medicine marks the beginning of a new attitude in medicine

EMBO Reports

Volumn 16, Issue 2, 2015, Pages 133-136

  Pavelic, Krešimir ^a   Martinovic, Tamara ^a   Kraljevic Pavelic, Sandra ^a  

^a University of Rijeka   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICINE; BREAST CANCER; COMMUNITY; GENETICS; GENOMICS; HEALTH CARE; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICAL SCHOOL; NUCLEOTIDE SEQUENCE; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; TRANSCRIPTOMICS; ATTITUDE TO HEALTH; PATIENT CARE;

ATTITUDE TO HEALTH; PATIENT-CENTERED CARE; PRECISION MEDICINE;

EID: 84922256180     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.15252/embr.201439609     Document Type: Article

References (4)

1. Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, et al,; North-East Japan Study Group (2010) Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 362: 2380-2388
2. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, et al,; BRIM-3 Study Group (2011) Improved survival with vemurafenib in melanoma with BRAF V600 mutation. N Engl J Med 364: 2507-2516
3. ESF Forward Look (2012) Personalised medicine for the European citizen. Towards more precise medicine for the diagnosis, treatment and prevention of disease (iPM). European Science Foundation, Strasbourg November
4. Hedgecoe A, (2004) The Politics of Personalised Medicine: Pharmacogenetics in the Clinic. New York: Cambridge University Press